RTW Investments, LP Reports New 8.3% Stake in CG Oncology, Inc. (CGON)

On May 15, 2026, RTW Investments, LP and Roderick Wong, M.D. filed a Schedule 13G disclosing a new 8.3% stake in CG Oncology, Inc. (CGON). The reporting persons collectively hold 6,984,808 shares of common stock as of the event date of March 31, 2026. This position represents a significant increase from 0.0% reported in previous filings. RTW Investments, LP serves as the investment adviser to certain funds that directly hold the shares, while Dr. Wong is the Managing Partner and Chief Investment Officer of the firm. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The ownership percentage is based on 84,435,200 shares outstanding as reported in the company's Annual Report for the period ending February 25, 2026. Both reporting persons share voting and dispositive power over the reported shares.